Melissa L. Johnson
9 Podcast Episodes
Soul-Deep Beauty | Melissa L. Johnson
Soul-Deep Beauty | Melissa L. Johnson
Are you being sold a broken brand of beauty?Beauty narratives our culture feeds us literally destroys lives. However, Go... Read more
28 May 2023
•
45mins
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
59mins
Similar People
Anita Rajasekhar
Ian W. Flinn
Gail J. Roboz
Roy H. Decker
Scott J. Antonia
Joshua Bauml
Steven B. Deitelzweig
Robert D. McBane
Stephen V. Liu
Edward S. Kim
Stephen A. Strickland
Ruben A. Mesa
Sorayah Bourenane
George L. Bakris
Jerry Vockley
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
59mins
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
59mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
59mins
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
59mins
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
59mins
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
59mins
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
19 Oct 2021
•
59mins
